Oncology Institute Stock (NASDAQ:TOI)
Previous Close
$5.43
52W Range
$2.19 - $5.82
50D Avg
$4.46
200D Avg
$3.65
Market Cap
$550.91M
Avg Vol (3M)
$1.71M
Beta
0.41
Div Yield
-
TOI Company Profile
The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.
TOI Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Health Care, Patient Service | $228.99M | $204.88M | $213.50M |
| Capitated Revenue | $80.48M | $68.69M | $70.37M |
| Fee For Service | $148.51M | $136.20M | $143.13M |
| Clinical Research Trials And Other Revenue | $4.56M | $8.61M | $6.90M |
| Dispensary Revenue | - | $179.92M | $103.83M |
Fiscal year ends in Dec 25 | Currency in USD